Board Meeting29 Apr 2026, 03:48 pm
Shukra Pharma Board to meet on May 7 for FY26 results & dividend
AI Summary
Shukra Pharmaceuticals Ltd has announced that its Board of Directors will convene on May 7, 2026. The primary agenda includes considering and approving the audited financial results for the quarter and financial year ended March 31, 2026, along with the Auditor's Report. Additionally, the Board will discuss and recommend a final dividend for the financial year 2025-26.
Key Highlights
- Board meeting scheduled for May 7, 2026.
- To consider and approve audited financial results for FY26.
- To recommend a final dividend for FY26.
Price Impact
More from SHUKRAPHAR